Content area

|
|

Behandling af rolandisk epilepsi

Forfatter(e)
Maria J. Miranda1 & Banoo Bakir Ahmad2 1) Børne- og Ungeafdelingen, Herlev Hospital 2) Panum Instituttet, Det Sundhedsvidenskabelige Fakultet, Københavns Universitet Ugeskr Læger 2017;179:V06170482
Reference: 
Ugeskr Læger 2017;179:V06170482
Blad nummer: 
Sidetal: 
2-7
Treatment of rolandic epilepsy
Recent literature indicates, that rolandic epilepsy/epilepsy of childhood with centrotemporal spikes may not be as benign as previously assumed. This study investigates the existing evidence, which describes the treatment effects on seizure frequency as well as improvement of cognition in children with rolandic epilepsy. We conclude, that treatment with anti-epileptic drugs could be justified, if treatment reduces seizures, prevents the evolution to atypical forms, or diminishes the negative cognitive consequences associated with the disease. Levetiracetam and sulthiame are the recommended treatments according to the existing evidence, which is still insufficient. A larger randomized controlled trial is warranted.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Sven Refslund Poulsen | 12/11
4 kommentarer
af Peter Tagmose Thomsen | 09/11
1 Kommentar
af Frank Bang Nissen | 09/11
1 Kommentar
af Frank Bang Nissen | 09/11
3 kommentarer
af Klaus Tage Mikal Tobiasen | 05/11
2 kommentarer
af Jørn Rosborg | 05/11
1 Kommentar
af Erik Kristensen | 02/11
3 kommentarer
af Peter Tagmose Thomsen | 01/11
1 Kommentar